IONS Q1 2017 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$12B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$116M+214.0% YoY

Gross Profit

$33M28.6% margin

Operating Income

$19M16.8% margin

Net Income

$9M7.7% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

-27.8%

Cash Flow

Operating Cash Flow

$123M

Free Cash Flow

$118M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$882M

Stockholders' Equity

$202M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$116M	$37M	+214.0%
Gross Profit	$33M	-$44M	+175.2%
Operating Income	$19M	-$55M	+135.7%
Net Income	$9M	-$63M	+114.2%